申请人:Rhone-Poulenc Industries
公开号:US04272534A1
公开(公告)日:1981-06-09
Compounds of the formula: ##STR1## wherein R represents hydrogen or alkyl of 1 through 4 carbon atoms, and R.sub.1 and R.sub.2 represent hydrogen or alkyl of 1 through 15 carbon atoms, or alkyl of 1 through 15 carbon atoms substituted by one substituent selected from (i) hydroxy, (ii) alkylamino in which the alkyl radical is of 1 through 4 carbon atoms, (iii) dialkylamino in which the alkyl radicals are of 1 through 4 carbon atoms, (iv) phenyl, (v) carboxy, and (vi) alkoxycarbonyl in which the alkoxy radical is of 1 through 4 carbon atoms, or R.sub.1 and R.sub.2 together with the nitrogen atom to which they are attached represent a five- or six-membered heterocyclic radical, are new compounds. They possess pharmacological properties and are particularly useful in the treatment of gastro-intestinal ulcers.
式子为:##STR1## 其中 R 代表氢或1至4个碳原子的烷基,R.sub.1 和 R.sub.2 代表氢或1至15个碳原子的烷基,或1至15个碳原子的烷基被选自以下一种取代基取代:(i) 羟基,(ii) 烷基胺,其中烷基基团为1至4个碳原子,(iii) 二烷基胺,其中烷基基团为1至4个碳原子,(iv) 苯基,(v) 羧基,以及 (vi) 烷氧羰基,其中烷氧基团为1至4个碳原子,或 R.sub.1 和 R.sub.2 与它们所连接的氮原子共同表示五元或六元杂环基团,这些化合物是新的。它们具有药理学特性,特别适用于治疗胃肠溃疡。